Contact

• workMedical School
  Royal Derby Hospital
  Uttoxeter Road
  Derby
  DE22 3DT
  UK
• Laura.Edwards@nottingham.ac.uk

Recent Publications

• EDWARDS L, 2023. Home-based virtual reality for help with symptoms of multiple sclerosis ISRCTN76033536
• CERUTTI C, EDWARDS LJ, DE VRIES HE, SHARRACK B, MALE DK and ROMERO IA, 2017. MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium Sci Rep. 7, 45284
• EDWARDS LJ, 2016. The neurology of autoimmune pernicious anaemia (subacute combined degeneration). In: CONTANSTINESCU C, ARSENESCU R and ARSENESCU V, eds., Neuroimmunogastroenterology Springer Science and Business Media.
• EDWARDS L and PHILLIPS M, 2016. Review of British Society for Rehabilitation/Royal College of Physicians meeting "Neuromusuclar conditions for physicians: what you need to know" Clin Med (Lond). 16(3), 259-261

• View all publications

• EDWARDS L, 2023. Home-based virtual reality for help with symptoms of multiple sclerosis ISRCTN76033536
• CERUTTI C, EDWARDS LJ, DE VRIES HE, SHARRACK B, MALE DK and ROMERO IA, 2017. MiR-126 and miR-126* regulate shear-resistant firm leukocyte adhesion to human brain endothelium Sci Rep. 7, 45284
• EDWARDS LJ, 2016. The neurology of autoimmune pernicious anaemia (subacute combined degeneration). In: CONTANSTINESCU C, ARSENESCU R and ARSENESCU V, eds., Neuroimmunogastroenterology Springer Science and Business Media.
• EDWARDS L and PHILLIPS M, 2016. Review of British Society for Rehabilitation/Royal College of Physicians meeting "Neuromusuclar conditions for physicians: what you need to know" Clin Med (Lond). 16(3), 259-261
• JEAN-GILLES L, BRAITCH M, LATIF ML, ARAM J, FAHEY AJ, EDWARDS LJ, ROBINS RA, TANASESCU R, TIGHE PJ, GRAN B, SHOWE LC, ALEXANDER SP, CHAPMAN V, KENDALL DA and CONSTANTINESCU CS, 2015. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells Acta Physiol (Oxf). 214(1), 63-74
• NEGM OH, HAMED MR, DILNOT EM, SHONE CC, MARSZALOWSKA I, LYNCH M, LOSCHER CE, EDWARDS LJ, TIGHE PJ, WILCOX MH and MONAGHAN TM, 2015. Profiling humoral immune responses to clostridium difficile-specific antigens by protein microarray analysis Clin Vaccine Immunol. 22(9), 1033-1039
• MANOUCHEHRINIA A, EDWARDS LJ, ROSHANISEFAT H and TENCH CR, 2015. Multiple sclerosis course and clinical outcomes in patients with comorbid asthma: a survey study BMJ Open. 5(5), e007806
• EDWARDS LJ, SHARRACK B, ISMAIL A, TENCH CR, GRAN B, DHUNGANA S, BRETTSCHNEIDER J, TUMANI H and CONSTANTINESCU CS, 2013. Increased levels of interleukin-2 and interleukin-17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension American Journal of Clinical and Experimental Immunology. 2(3), 234-244
• EDWARDS LJ and CONSTANTINESCU CS, 2013. Disease modifying treatments for secondary progressive and progressive relapsing MS. In: WEINSTOCK-GUTTMAN B, RAMANATHAN M and ZIVADINOV R, eds., Personalised Management of Multiple Sclerosis Future Science Group.
• EDWARDS LJ, 2013. Review of Society for Rehabilitation Research Meeting ACNR. 13(5), 37
• WEINER HL and EDWARDS LJ, 2012. Future therapeutic approaches. In: WEINER HL and STANCIEWICZ JM, eds., Multiple Sclerosis: Diagnosis and Therapy Wiley-Blackewell. 283
• CONSTANTINESCU CS, NIEPEL G, PATTERSON M, JUDD A, BRAITCH M, FAHEY AJ, HARIKRISHNAN S, EDWARDS LJ, TENCH CR, BENNETT GW and GHATEI M, 2011. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness J Neurol Sci. 307(1-2), 127-131
• EDWARDS LJ, SHARRACK B, ISMAIL A, TUMANI H and CONSTANTINESCU CS, 2011. Central inflammation versus peripheral regulation in multiple sclerosis J Neurol. 258(8), 1518-1527
• EDWARDS LJ and CONSTANTINESCU CS, 2011. Disease-modifying therapy - effectiveness-safety balance. In: THORNHILL C, ed., Hospital Pharmacy Europe - Multiple Sclerosis Supplement
• EDWARDS LJ, ROBINS RA and CONSTANTINESCU CS, 2010. Th17/Th1 phenotype in demyelinating disease Cytokine. 50(1), 19-23
• EDWARDS L and CONSTANTINESCU C, 2010. Cytokines in idiopathic intracranial hypertension CSF Headache. 50(2), 323-235
• EDWARDS LJ and CONSTANTINESCU CS, 2009. Platelet activating factor/platelet activating factor receptor pathway as a potential therapeutic target in autoimmune diseases Inflamm Allergy Drug Targets. 8(3), 182-190
• EDWARDS LJ and CONSTANTINESCU CS, 2009. Parasite immunomodulation in autoimmune disease: focus on multiple sclerosis Expert Rev Clin Immunol. 5(5), 487-489
• BRAITCH, M., NUNAN, R., NIEPEL, G., EDWARDS, L.J. and CONSTANTINESCU, C.S., 2008. Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis JAMA Neurology. 65(5), 633-635
• EDWARDS, LJ, DUA, H and CONSTANTINESCU, CS, 2008. Symptomatic uveitis and multiple sclerosis Clinical Science. 32(2), 49-54
• EDWARDS LJ, ATHERTON JC, ZAITOUN AM and CONSTANTINESCU CS, 2008. A case of dysphagia with clinically isolated syndrome Mult Scler. 14(5), 716-717
• EDWARDS LJ, TALLANTYRE E, BOSLEY TM, GOTTLOB I and CONSTANTINESCU CS, 2008. Optic Neuritis. In: LEWIS BN and DAVIES CJ, eds., Optic Nerve Disease Research Perspectives Nova Publishers.
• EDWARDS LJ, TENCH CR, GILMORE CP, EVANGELOU N and CONSTANTINESCU CS, 2007. Multiple sclerosis findings in the spinal cord Expert Rev Neurother. 7(9), 1203-1211
• EDWARDS LJ and CONSTANTINESCU CS, 2004. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic Mult Scler. 10(5), 575-581
• EDWARDS LJ, 2000. Exploring the Species BMJ Student. 8, 247
• JIMENEZ-LINAN LM, EDWARDS L, ABISHEK A and DOHERTY M, Online patient information resources on gout provide inadequate information and minimal emphasis on potentially curative urate lowering treatment Arthritis Care and Research. (In Press.)